Tuning the Code: Preventing Aberrant Translation to Unlock Safer, Stronger mRNA Immunotherapies
This seminar will take place in person only
Dr James Thaventhiran is a Principal Investigator and Theme Lead at the MRC Toxicology Unit, University of Cambridge, where he investigates how adaptive immune lymphocytes resist anti-proliferative inflammatory signals. He is also a clinical immunologist at Addenbrooke’s Hospital, where his clinical studies on patients with primary and secondary immunodeficiency have the goal of identifying novel immunodeficiencies and therapies.
Date: 24 September 2025, 12:00
Venue: Old Road Campus Research Building, Headington OX3 7DQ
Venue Details: Rooms 71 a/b/c (Ground floor)
Speaker: Dr James Thaventhiran (MRC Toxicology Unit, University of Cambridge; Addenbrooke’s Hospital)
Organising department: Department of Oncology
Organiser: Yuliia Karpenko
Organiser contact email address: adminsupport@oncology.ox.ac.uk
Host: Professor Benjamin Fairfax (University of Oxford)
Booking required?: Not required
Booking email: adminsupport@oncology.ox.ac.uk
Audience: Members of the University only
Editor: Yuliia Karpenko